EA200300900A1 - Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты) - Google Patents

Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты)

Info

Publication number
EA200300900A1
EA200300900A1 EA200300900A EA200300900A EA200300900A1 EA 200300900 A1 EA200300900 A1 EA 200300900A1 EA 200300900 A EA200300900 A EA 200300900A EA 200300900 A EA200300900 A EA 200300900A EA 200300900 A1 EA200300900 A1 EA 200300900A1
Authority
EA
Eurasian Patent Office
Prior art keywords
variants
preparation
options
composition
substituted amino
Prior art date
Application number
EA200300900A
Other languages
English (en)
Other versions
EA006636B1 (ru
Inventor
Иэн Игл
Уильям Дилейни
Чжаоцин Ван
Ричард Шумахер
Аллан Т. Хоппер
Ашок Техим
Шон Мэддейфорд
Original Assignee
Эллеликс Ньюросайенс, Инк.
эНПиэС ЭЛЛЕЛИКС КОРП.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23026417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200300900(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эллеликс Ньюросайенс, Инк., эНПиэС ЭЛЛЕЛИКС КОРП. filed Critical Эллеликс Ньюросайенс, Инк.
Publication of EA200300900A1 publication Critical patent/EA200300900A1/ru
Publication of EA006636B1 publication Critical patent/EA006636B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Abstract

В изобретении описан фармацевтический препарат для лечения неврологических и нейропсихических нарушений, содержащий соединение формулы Iили его фармацевтически приемлемую соль.Отчет о международном поиске был опубликован 2002.10.17.
EA200300900A 2001-02-16 2002-02-15 Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты) EA006636B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26924101P 2001-02-16 2001-02-16
PCT/CA2002/000176 WO2002066456A2 (en) 2001-02-16 2002-02-15 Thiophene substituted amine derivatives as glyt-1 inhibitors

Publications (2)

Publication Number Publication Date
EA200300900A1 true EA200300900A1 (ru) 2004-02-26
EA006636B1 EA006636B1 (ru) 2006-02-24

Family

ID=23026417

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300900A EA006636B1 (ru) 2001-02-16 2002-02-15 Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты)

Country Status (31)

Country Link
US (1) US6667336B2 (ru)
EP (1) EP1368336B9 (ru)
JP (2) JP2004523548A (ru)
KR (1) KR100900020B1 (ru)
CN (1) CN1219776C (ru)
AT (1) ATE327986T1 (ru)
AU (1) AU2002235682C1 (ru)
BG (1) BG108164A (ru)
BR (1) BR0207307A (ru)
CA (1) CA2438367A1 (ru)
CY (1) CY1105529T1 (ru)
CZ (1) CZ20032503A3 (ru)
DE (1) DE60211866T2 (ru)
DK (1) DK1368336T3 (ru)
EA (1) EA006636B1 (ru)
EE (1) EE05329B1 (ru)
ES (1) ES2266446T3 (ru)
HK (1) HK1061025A1 (ru)
HR (1) HRP20030696A2 (ru)
HU (1) HUP0303185A3 (ru)
IL (1) IL157194A (ru)
MX (1) MXPA03007309A (ru)
NO (1) NO329038B1 (ru)
NZ (1) NZ527695A (ru)
PL (1) PL365024A1 (ru)
PT (1) PT1368336E (ru)
SI (1) SI1368336T1 (ru)
SK (1) SK287304B6 (ru)
UA (1) UA75114C2 (ru)
WO (1) WO2002066456A2 (ru)
ZA (1) ZA200307201B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
DK1830833T3 (da) * 2004-12-16 2010-05-17 Janssen Pharmaceutica Nv Kombination af en glycintransportør (GLyT1) inhibitor og et antipsykotikum til behandling af symptomer på schizofreni samt dens fremstilling og anvendelse deraf
US20090253918A1 (en) * 2006-10-02 2009-10-08 Janssen Pharmaceuticals, N.V. Novel intermediate for glyt1 inhibitor
WO2008065500A2 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Heteroaryl amides as type i glycine transport inhibitors
CN103374057B (zh) * 2012-04-16 2015-08-19 中国医药集团总公司四川抗菌素工业研究所 一种对甘氨酸转运子具有抑制活性的化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3050800C2 (ru) 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
BE885303A (fr) 1980-09-19 1981-03-19 Continental Pharma Glycinamides
AU552050B2 (en) 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
US4383999A (en) 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
US4514414A (en) 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
DK288385D0 (da) 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US4772615A (en) 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
FI864246A (fi) 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
EP0231996B1 (en) 1986-01-07 1993-10-06 Novo Nordisk A/S Novel amino acid derivatives
JPH02129158A (ja) 1988-11-07 1990-05-17 Nippon Steel Corp 光学活性なグリシン誘導体及びその製造方法
IE913279A1 (en) * 1990-09-26 1992-04-08 Astra Ab (2-Thienyl)alkylamine Derivatives Having Neuroprotective¹Properties
ES2036926B1 (es) 1991-08-08 1994-01-16 Uriach & Cia Sa J "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
DK0871440T3 (da) 1995-12-07 2006-07-10 Daniel C Javitt Behandling af negative og kognitive symptomer på skizofreni med glycinoptagelsesantagonister
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
ATE334668T1 (de) * 1996-05-31 2006-08-15 Allelix Neuroscience Inc Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
KR100385662B1 (ko) * 1998-01-09 2003-05-28 화이자 인코포레이티드 매트릭스 메탈로프로테아제 억제제
US6103743A (en) * 1999-08-06 2000-08-15 Allelix Neuroscience, Inc. Unsaturated amino acid derivatives

Also Published As

Publication number Publication date
SK287304B6 (sk) 2010-06-07
NO329038B1 (no) 2010-08-02
AU2002235682B2 (en) 2007-04-26
SK11442003A3 (sk) 2004-03-02
ES2266446T3 (es) 2007-03-01
ZA200307201B (en) 2004-07-28
EA006636B1 (ru) 2006-02-24
HUP0303185A2 (hu) 2003-12-29
BR0207307A (pt) 2004-08-17
CY1105529T1 (el) 2010-07-28
SI1368336T1 (sl) 2006-10-31
DK1368336T3 (da) 2006-10-02
EE05329B1 (et) 2010-08-16
CZ20032503A3 (cs) 2004-02-18
JP2004523548A (ja) 2004-08-05
HUP0303185A3 (en) 2008-12-29
IL157194A (en) 2006-12-31
US6667336B2 (en) 2003-12-23
HRP20030696A2 (en) 2005-04-30
AU2002235682C1 (en) 2008-12-11
WO2002066456A3 (en) 2002-10-17
NZ527695A (en) 2005-05-27
PL365024A1 (en) 2004-12-27
DE60211866D1 (de) 2006-07-06
BG108164A (en) 2004-07-30
EE200300394A (et) 2003-12-15
MXPA03007309A (es) 2004-06-30
KR20040028719A (ko) 2004-04-03
NO20033634D0 (no) 2003-08-15
CN1219776C (zh) 2005-09-21
DE60211866T2 (de) 2007-06-14
ATE327986T1 (de) 2006-06-15
HK1061025A1 (en) 2004-09-03
CA2438367A1 (en) 2002-08-29
PT1368336E (pt) 2006-10-31
EP1368336A2 (en) 2003-12-10
CN1491221A (zh) 2004-04-21
WO2002066456A2 (en) 2002-08-29
EP1368336B9 (en) 2007-02-14
US20030176489A1 (en) 2003-09-18
NO20033634L (no) 2003-10-08
JP2010059182A (ja) 2010-03-18
EP1368336B1 (en) 2006-05-31
UA75114C2 (en) 2006-03-15
KR100900020B1 (ko) 2009-06-01

Similar Documents

Publication Publication Date Title
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
EA200300788A1 (ru) Производные замещенных алкиламинов и их применение
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
EA200400283A1 (ru) Производные аминофталазинона, активные как ингибиторы киназ, способ их получения и содержащие их фармацевтические композиции
ATE440603T1 (de) 8-hydroxychinolinderivate
EA200300527A1 (ru) Новые способы лечения синдрома "усталых ног"
DE602004014791D1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
WO2004022528A3 (en) Arylglycine derivatives and their use as glycine transport inhibitors
DK0669912T3 (da) N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
BG106293A (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
SE0002729D0 (sv) Novel compound form
EA200300900A1 (ru) Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты)
CY1108259T1 (el) Ανταγωνιστες υποδοχεα διεγερτικου αμινοξεος
SE0100295D0 (sv) New compounds
BR0214552A (pt) Composto ou um seu sal de adição de ácido farmaceuticamente aceitável, composição farmacêutica, uso do composto ou do seu sal de adição de ácido farmaceuticamente aceitável, e, método para o tratamento de uma doença
EA200300782A1 (ru) Пролекарства возбуждающих аминокислот
BR9604914A (pt) Inibidores de agregaçao de plaquetas contendo resíduos de aminoácido de cadeia lateral aminérgicos c-terminais
EA201001895A1 (ru) Пролекарства возбуждающих аминокислот

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU